... AAV and lentiviral transient gene therapy production technologies by licensing to both CMOs and therapeutics manufacturers across the globe.
https://www.google.com/url?rct=j&sa=t&url=https://www.biopharma-reporter.com/Article/2021/01/12/New-antibody-discovery-platform-could-help-accelerate-CAR-T-therapeutic-development&ct=ga&cd=CAIyGmEyNDJjNTAxZWU3OTQyNzI6Y29tOmVuOlVT&usg=AFQjCNFmHYEJ0FQZ1lYt6ZpnCv-TyaEcFw
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.